Founded in 2007, Arcus Ventures invests in oncology-focused companies with advanced biopharmaceuticals and is a private equity company.
Business Model:
Revenue: $11.9M
Employees: 2-10
Address: 60 E 42nd St
City: New York
State: NY
Zip: 10165
Country: US
Arcus Ventures is a private equity firm that invests in oncology-focused companies with advanced biopharmaceuticals. It also finances new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue. Arcus Ventures was founded in 2007 by Steven L. Soignet, and James B. Dougherty. It is headquartered in New York, United States.
Contact Phone:
+12127852236
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2013 | T2 Biosystems | Series E | 40M |
11/2010 | Vascular Pathways | Series B | 0 |
5/2011 | MI Bioresearch | Series A | 7M |
3/2012 | MI Bioresearch | Series A | 9.9M |
7/2017 | Exosome Diagnostics | Series C | 0 |
3/2014 | Exosome Diagnostics | Series B | 0 |
4/2011 | TRACON Pharmaceuticals | Series A | 14M |
5/2010 | T2 Biosystems | Series C | 0 |
7/2014 | Epic Sciences | Series C | 0 |
1/2016 | Exosome Diagnostics | Series B | 0 |
10/2013 | MI Bioresearch | Series B | 0 |
8/2016 | Cleave Therapeutics | Series B | 0 |
9/2014 | TRACON Pharmaceuticals | Series B | 0 |
8/2019 | Cleave Therapeutics | Series C | 0 |
10/2008 | MacroGenics | Series D | 25M |
8/2009 | Palyon Medical | Series A | 24M |
9/2015 | Exosome Diagnostics | Series B | 0 |
8/2011 | T2 Biosystems | Series D | 0 |
6/2015 | XTuit Pharmaceuticals | Series A | 22M |
8/2019 | Cleave Therapeutics | Series C | 0 |
7/2017 | Exosome Diagnostics | Series C | 0 |
8/2016 | Cleave Therapeutics | Series B | 0 |
1/2016 | Exosome Diagnostics | Series B | 0 |
9/2015 | Exosome Diagnostics | Series B | 0 |
6/2015 | XTuit Pharmaceuticals | Series A | 0 |
9/2014 | TRACON Pharmaceuticals | Series B | 0 |
7/2014 | Epic Sciences | Series C | 0 |
3/2014 | Exosome Diagnostics | Series B | 0 |
10/2013 | MI Bioresearch | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|